Trial · NCT01254864
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Abiraterone Acetate+Prednisone(AP) Phase | STARTED | Abiraterone Acetate + Prednisone (AP) | 179 | |
| Abiraterone Acetate+Prednisone(AP) Phase | STARTED | AP + Sunitinib | 0 | |
| Abiraterone Acetate+Prednisone(AP) Phase | STARTED | AP + Dasatinib | 0 | |
| Abiraterone Acetate+Prednisone(AP) Phase | Randomized to AP + Sunitinib | Abiraterone Acetate + Prednisone (AP) | 64 | |
| Abiraterone Acetate+Prednisone(AP) Phase | Randomized to AP + Sunitinib | AP + Sunitinib | 0 | |
| Abiraterone Acetate+Prednisone(AP) Phase | Randomized to AP + Sunitinib | AP + Dasatinib | 0 | |
| Abiraterone Acetate+Prednisone(AP) Phase | Randomized to AP + Dasatinib | Abiraterone Acetate + Prednisone (AP) | 68 | |
| Abiraterone Acetate+Prednisone(AP) Phase | Randomized to AP + Dasatinib | AP + Sunitinib | 0 | |
| Abiraterone Acetate+Prednisone(AP) Phase | Randomized to AP + Dasatinib | AP + Dasatinib | 0 | |
| Abiraterone Acetate+Prednisone(AP) Phase | Crossover to AP + Sunitinib | Abiraterone Acetate + Prednisone (AP) | 0 | |
| Abiraterone Acetate+Prednisone(AP) Phase | Crossover to AP + Sunitinib | AP + Sunitinib | 0 | |
| Abiraterone Acetate+Prednisone(AP) Phase | Crossover to AP + Sunitinib | AP + Dasatinib | 0 | |
| Abiraterone Acetate+Prednisone(AP) Phase | Crossover to AP + Dasatanib | Abiraterone Acetate + Prednisone (AP) | 0 | |
| Abiraterone Acetate+Prednisone(AP) Phase | Crossover to AP + Dasatanib | AP + Sunitinib | 0 | |
| Abiraterone Acetate+Prednisone(AP) Phase | Crossover to AP + Dasatanib | AP + Dasatinib | 0 | |
| Abiraterone Acetate+Prednisone(AP) Phase | COMPLETED | Abiraterone Acetate + Prednisone (AP) | 132 | |
| Abiraterone Acetate+Prednisone(AP) Phase | COMPLETED | AP + Sunitinib | 0 | |
| Abiraterone Acetate+Prednisone(AP) Phase | COMPLETED | AP + Dasatinib | 0 | |
| Abiraterone Acetate+Prednisone(AP) Phase | NOT COMPLETED | Abiraterone Acetate + Prednisone (AP) | 47 | |
| Abiraterone Acetate+Prednisone(AP) Phase | NOT COMPLETED | AP + Sunitinib | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01254864/flow